combat

COMBAT - Updated biosecurity tool with 4 features

Read now
Cover Guilty Gilt

The Guilty Gilt Guide

Read now
PRRS Ctrl

PRRS Ctrl 2.0

Download for free
prrs-awards-placeholder

The 11th European PRRS Research Awards

Discover now
  • combat
    COMBAT - Updated biosecurity tool with 4 features
  • Cover Guilty Gilt
    The Guilty Gilt Guide
  • PRRS Ctrl
    PRRS Ctrl 2.0
  • prrs-awards-placeholder
    The 11th European PRRS Research Awards
October 2024
18
19
20
21
22
23
24
25
26
27
28
29
30
31
November 2024
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
December 2024
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
PRRS Introduction & Welcome Image

PRRS Introduction & Welcome

Asian PRRS Talk: Meet the Experts Live on demand

Video preview image
Expertise article

Impact of sow herd vaccination against Porcine Reproductive and Respiratory Syndrome Virus type 1 (PRRSV-1) on reproductive performance on a one-site farm in Serbia

PRRSV can cause significant impact on reproductive performance in endemically infected herds. This study aimed to investigate sow performance before and after implementation of a sow herd vaccination against PRRSV on a farm in Serbia.

Comparative efficacy of INGELVAC PRRS® MLV against a heterologous PRRSV 1 7 4 challenge
Expertise video

Comparative efficacy of INGELVAC PRRS® MLV against a heterologous PRRSV 1 7 4 challenge

The use of INGELVAC PRRS vaccines can significantly reduce lung lesions following challenge with heterologous isolates (86- 94% ORF5 nucleotide similarity) in the three-week-old pig respiratory challenge model.1 INGELVAC PRRS MLV demonstrated heterologous protection against challenge with current PRRSV lineage-1 RFLP 1-7-4 and 1-3-4 isolates.2 The objective of this study was to evaluate the efficacy of two commercially available PRRSV vaccines in a three-week-old pig respiratory challenge model, using a heterologous PRRSV lineage-1 RFLP 1-7-4 field strain that was isolated in 2016.

img
Expertise article

Vaccination against porcine parvovirus protects against disease, but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain

The demonstration of field isolates of porcine parvovirus (PPV) that differ genetically and antigenically from vaccine strains of PPV raises the question of whether the broadly used inactivated vaccines can still protect sows against the novel viruses.

bite-size-img-1
Bite size

Why is IgG important?

Meet the Expert Bite Sizes with Rutger Jansen.

Roundtable discussion  II
American PRRSpective | AM 2024

American PRRSpective 2024 – Roundtable discussion II

Dive into the dynamic discussions, insightful presentations, and vibrant exchanges that made this event unforgettable. Whether you're reliving your favorite moments or discovering new insights, these videos offer an immersive journey through the heart of our community's knowledge exchange.

Feb23_Portada
Content Compass | February 2023

February 2023 - Content Compass

Content Compass, the ultimate guidebook, keeps you informed of the latest scientific and practical advancements in PRRS Disease Control and Management.